Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.
about
The gut hormones in appetite regulationGlucagon-like peptide analogues for type 2 diabetes mellitusDysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetesGPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesityOne-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trialGlucagon-like peptide 1 improved glycemic control in type 1 diabetesMechanisms of action of glucagon-like peptide 1 in the pancreasIncretin-based drugs for type 2 diabetes: Focus on East Asian perspectivesPancreatic regulation of glucose homeostasisExenatide once-weekly injection for the treatment of type 2 diabetes in Chinese patients: current perspectivesA clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyondAssessment of pancreatic β-cell function: review of methods and clinical applicationsIncretins and the intensivist: what are they and what does an intensivist need to know about them?Effects of GLP-1 on appetite and weightA high-protein diet for reducing body fat: mechanisms and possible caveatsDietary proteins as determinants of metabolic and physiologic functions of the gastrointestinal tractGlucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic SuccessesGlucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signalingNovel GLP-1 fusion chimera as potent long acting GLP-1 receptor agonistA novel glucagon-related peptide (GCRP) and its receptor GCRPR account for coevolution of their family members in vertebratesHeterologous Expression and Delivery of Biologically Active Exendin-4 by Lactobacillus paracasei L14The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodentsExtrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.Boc5, a non-peptidic glucagon-like Peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic micePreclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor AgonistsCMD-05, a novel promising clinical anti-diabetic drug candidate, in vivo and vitro studiesβ-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment.Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults.Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus.Obesity treatment: novel peripheral targets.GIP and GLP-1, the two incretin hormones: Similarities and differencesRole and development of GLP-1 receptor agonists in the management of diabetes.Combinations of drugs in the Treatment of Obesity.Liraglutide Therapy for Type 2 Diabetes: Overcoming Unmet NeedsGLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?The incretin system and cardiometabolic disease
P2860
Q21296779-EA556B5A-09CE-4C29-B0CF-3D06C59FBD43Q24243685-4304FDF9-C62F-4CA5-B375-C7AC0AFE3A99Q24564844-8E4388C2-34F7-4063-B2CE-1810E0E35ABEQ24653673-E951535E-F106-4C64-80FE-04652131F075Q24656644-6B2DDF96-4204-4805-96F3-148861282A1EQ24678588-932E06FD-5D56-408A-BEA4-861D1A39E8A0Q24683764-8FD5E78F-6441-4DAC-8B5B-303326D20F27Q26749165-DC980C65-1D3B-4C44-8B32-96B4CC0C7E55Q26766485-69E45891-4275-4F37-BE99-CAA2400FCCBAQ26797236-C6BF58CF-B5D4-4C35-85F4-50D1C521449BQ26799389-E55EA0B3-1193-46F5-AAB6-DB119212DB0FQ26829445-7F8F9209-729F-4313-B5CF-C2263927937DQ26995464-76991122-97AB-4BBF-B950-85F0A8DF6F67Q27011627-E1403DB3-2AA2-4C0E-B4D7-73AB8974D196Q27016162-5908A17A-15C0-4BBC-BC7D-FED7FD0CB297Q27022611-605215DE-813A-4E5B-90A4-86B5C7D40D1CQ27863799-3E487F42-E0BB-48AB-8498-0512074E264CQ28067465-552E0118-42E3-4E60-A2F7-27D52F36177DQ28084873-E3F92494-4897-4E57-A828-DF5715CC2A2AQ28475510-F515820C-7940-4D25-9D2B-B6C2C5BC9CE2Q28533808-62EE356D-CC05-42C8-8250-998B111AF6FDQ28552845-9B90BF1A-3F0E-429E-AB67-C6EA7867E89BQ28598004-C5B50FBD-2147-432E-A4F2-2EC223B4DA39Q30478488-64C9215C-7B64-480E-8F74-84223913D9D4Q30597265-70298E8F-AA4B-4C92-A7D9-ACC7B85AD034Q33225025-F6D6D035-5EEB-4F0D-866A-21230E4ED4F3Q33268721-A5D951CD-1F2D-4F48-915E-54EB3CB6D29BQ33358112-476A4D90-4B27-47DD-94C0-6C472883E321Q33521451-CE6B1F13-E06F-4496-9505-16C19EB1CE58Q33559925-DC6787ED-E0C0-4383-9629-BFE300409DFCQ33570085-4BD694D7-0491-4551-A5A4-D8E9EE706A37Q33570118-02B5C80A-8891-4D55-BF65-98CC2AE11AA7Q33603466-DC2E9E93-1856-4C17-931A-6539354F1381Q33607971-A26AC675-FC89-45E0-86D4-66862B66B07BQ33609502-0F8B7648-9780-4AFC-91F5-27DC72B33993Q33635830-5CB5CBBC-3295-48C1-88C9-4FFD92FC6D9CQ33664063-240264A0-2DB0-4E3A-AFC6-E7C9FC308093Q33664253-6D1CBB64-5185-47E8-82B5-B00821F33BC4Q33734024-73200FD8-28A3-4E6B-8A5B-2574F923E7ADQ33776092-A49387CF-E04C-4822-9FC2-46ED7847470D
P2860
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Effect of 6-week course of glu ...... betes: a parallel-group study.
@en
Effect of 6-week course of glu ...... betes: a parallel-group study.
@nl
type
label
Effect of 6-week course of glu ...... betes: a parallel-group study.
@en
Effect of 6-week course of glu ...... betes: a parallel-group study.
@nl
prefLabel
Effect of 6-week course of glu ...... betes: a parallel-group study.
@en
Effect of 6-week course of glu ...... betes: a parallel-group study.
@nl
P1433
P1476
Effect of 6-week course of glu ...... betes: a parallel-group study.
@en
P2093
Jan Lysgaard Madsen
Mette Zander
P304
P356
10.1016/S0140-6736(02)07952-7
P407
P577
2002-03-01T00:00:00Z